Hydrocort 1 A Pharma (Hydrocortisone)

Hydrocort 1 A Pharma is indicated for the topical treatment of several common inflammatory skin disorders where reduction of redness, itching, and swelling is desired. It is typically applied to affected areas once or twice daily, depending on clinical guidance.

• Eczema (atopic dermatitis) – mild to moderate flare‑ups.
• Contact dermatitis caused by allergens or irritants.
• Psoriasis plaques that respond to low‑potency corticosteroids.
• Allergic skin reactions such as hives or insect bites.
• Seborrheic dermatitis of the scalp or face.

• Hydrocortisone exerts its anti‑inflammatory activity by diffusing across the cell membrane and binding to intracellular glucocorticoid receptors. The drug‑receptor complex translocates to the nucleus, where it interacts with glucocorticoid response elements on DNA, modulating transcription of multiple genes. This results in decreased synthesis of pro‑inflammatory cytokines, prostaglandins, and leukotrienes, while enhancing production of anti‑inflammatory proteins, thereby reducing edema, erythema, and pruritus in the skin.

Topical hydrocortisone may cause local and, rarely, systemic adverse reactions, which are generally categorized by frequency and severity.

Common

• Skin irritation, burning, or stinging at the application site.
• Mild dryness or peeling of the treated skin.
• Temporary worsening of acne or folliculitis.
• Slight discoloration (hypopigmentation) of the skin.
• Increased sensitivity to sunlight (photosensitivity).

Serious

• Development of skin atrophy or thinning with prolonged use.
• Secondary bacterial, fungal, or viral infection of the treated area.
• Allergic contact dermatitis to the formulation.
• Systemic absorption leading to adrenal suppression (rare).
• Elevated intraocular pressure or cataract formation with extensive application.

When using Hydrocort 1 A Pharma, several precautionary measures should be observed to minimize risks and ensure safe application.

• Avoid applying to broken, infected, or ulcerated skin unless directed by a healthcare professional.
• Limit duration of use; prolonged therapy may increase risk of skin atrophy and systemic effects.
• Do not use under occlusive dressings unless specifically prescribed.
• Use with caution in patients with diabetes, hypertension, or known glaucoma.
• Pregnant or breastfeeding individuals should consult a clinician before use.
• Keep out of reach of children; accidental ingestion can cause systemic corticosteroid effects.

Hydrocort 1 A Pharma may interact with other topical agents or systemic medications that affect corticosteroid metabolism or skin integrity.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area.
• Application together with topical antibiotics or antifungals that may increase irritation risk.

Use with caution

• Systemic glucocorticoids, as combined effects can enhance systemic exposure.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied to the same site, which may increase local irritation.
• Phototherapy or UV‑light treatments, due to heightened photosensitivity.
• Herbal or over‑the‑counter skin products containing retinoids or salicylic acid.